The Medical Research Council trials in adult acute lymphocytic leukemia (Q34123858)

31 July 2017

1 reference

title

The Medical Research Council trials in adult acute lymphocytic leukemia (English)

1 reference

31 July 2017

0 references

1 reference

I J Durrant

1 reference

31 July 2017

S M Richards

series ordinal

1 reference

31 July 2017

H G Prentice

series ordinal

1 reference

31 July 2017

A H Goldstone

series ordinal

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Hematology / Oncology Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

1327-1352

1 reference

Bone marrow transplantation for acute lymphoblastic leukaemia

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: Results of CALGB protocol 7113

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Effects of varying radiation schedule, cyclophosphamide treatment, and duration of treatment in acute lymphoblastic leukaemia. Report to the Medical Research Council by the Working Party on Leukaemia in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III: the effects of added cytosine arabinoside and/or asparaginase, and a comparison of continuous or discontinuous mercaptopurine in regimens for standard risk ALL

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970189-1

7 January 2021

10.1016/S0889-8588(05)70189-1

Identifiers

DOI

1 reference

31 July 2017

1 reference